Large-scale genome-wide association studies (GWAS) have identified a set of common genetic variants in glutamatergic genes in patients with schizophrenia, including, for instance, GRM3, GRIN2A, GRIA1, SRR, CLCN3, among others38,39. Here, GRIA1 is linked to schizophrenia.